[1]
De Francesco, M., Lamotte, M., Ascierto, P.A., Di Rienzo, P. and Asukai, Y. 2016. Economic Evaluation of Ipilimumab in First Line Treatment of Advanced Melanoma in Italy. Global and Regional Health Technology Assessment. 3, 2 (Jul. 2016), 67–79. DOI:https://doi.org/10.33393/grhta.2016.412.